Peter Zhukovsky

Scientist at the Brain Health Imaging Center, CAMH 🇨🇦 @CAMHResearch; previously @McLeanHospital, @Cambridge_Uni, precision psychiatry
*stop the war* 🇺🇦

[Bratislav Misic @misicbata]

Benchmarking methods for mapping functional connectivity in the brain | https://t.co/N2XmnTJXsA

What is the best FC metric?

led by @liuzhenqi0303 in @naturemethods ⤵️

[James Pang @jchrispang]

Applications for our postdoc position closes in 6 days! (Deadline: May 18 11:55pm AEST)

If you are interested in MRI, modelling of brain dynamics, and genetics in health, disease, or across evolution, we would love for you to join our team👇👇

[The CAN-BIND Depression Network @CANBIND]

🚀 CAN-BIND Multi-Modal Data Sets in Action at @SOBP 2025!

A huge shout-out to Dr. Eric Ruhé for leading a stellar symposium, with Dr. Peter Zhukovsky @peterzhukovsky, Dr. Matthan Caan, and the CAN-BIND platform leaders Dr. Faranak Farzan @faranakfarzan & Dr. Jane Foster @jfosterlab showcasing how integrated neuroimaging, EEG, gut microbiome, EMBARC & CAN-BIND datasets can help predict treatment outcomes in mental health care. 🧠✨

👏 Special thanks to Dr. Benicio Frey, the Director of CAN-BIND, for wrapping up the session with a compelling vision for the future of mental health care powered by multi-modal data research.

🔬 The CAN-BIND dataset is available to researchers through the Ontario Brain Institute @OntarioBrain.🧠

https://t.co/eS2SzuyGgt

#MentalHealth #PrecisionMedicine #SOBP2025 #DataScience

[Emily Belleau @belleau_emily]

Hello colleagues,

I have just received my first NIMH funded R01 and am looking to hire a postdoctoral fellow. Please spread the word! Here is the link for details about our team and the position! https://t.co/iCX0Bmq0pU

[Povilas Karvelis @KarvelisPovilas]

Just launched the E2P Simulator - an interactive open-source tool that translates effect sizes into predictive utility 🧠

Check it out here: https://t.co/kfInGnZuF2

Many areas of research, such as biomedical, behavioral, educational, and sports sciences are studying individual differences in order to build predictive models to personalize treatment, learning, and training.

However, common research practices are hindering these efforts by overinterpreting effect sizes and by neglecting measurement reliability & outcome base rates.

E2P Simulator aims to address this conglomerate of issues. Similar to how G*Power helps researchers plan for statistical significance, E2P Simulator helps plan for practical significance.

Academic papers demonstrating its utility will be coming soon! In the meantime, you can find examples on how to use it on the "Get Started" page.

Feedback/suggestions are very welcome, more features are planned too 😉

[Nicholas Ashton @NicholasAshton]

We're entering a new era of #Alzheimers blood testing—fully automated platforms now deliver fast, accurate #pTau217 results for use in primary & secondary care.

Proud to share senior authorship and proud of this multi-centre European collaboration.

🔗 https://t.co/X2bTAEVAee

[Peter Zhukovsky @peterzhukovsky]

Looking forward to following up these results with @DiegoPizzagalli @GregAppelbaum @JMurrough and many others @CAMHnews!

[Peter Zhukovsky @peterzhukovsky]

Very happy to see our paper with @DiegoPizzagalli and EMBARC and CANBIND investigators published in @JAMANetworkOpen, featured on JAMA+AI:
https://t.co/mJXACQGfYi
Important first steps in identifying robust, cross-trial biomarkers of depression treatment response
more below⬇️

[Diego A. Pizzagalli, PhD @DiegoPizzagalli]

1/2: Important new findings by @peterzhukovsky, a former postdoc in the lab and now faculty at @CAMHResearch, who identified a neural (rsfMRI) marker that predicted SSRI treatment.

[Peter Zhukovsky @peterzhukovsky]

After bootstrapping we show moderate cross-trial generalizability of models including the resting state fMRI marker (AUC in the range of 0.62-0.70 and balanced accuracy range of 63-71%), which is less than within-trial prediction performance, but an improvement vs clinical model

[Jake Vogel @_JakeVogel_]

‼️PhD Position now available in my lab‼️

Do you like:
* Neurodegenerative disease?
* Neuroimaging and/or multi-omics?
* AI and data-driven life science?

Want to work with @RikOssenkoppele Alexandra Young and Laura Wisse?

Apply here: https://t.co/aQ3g5pZWJe

Please rt/share 🙏

[Diego A. Pizzagalli, PhD @DiegoPizzagalli]

1/18: Well, after 23 years as faculty at Harvard and almost 15 years of amazing collaborations, collegiality and growth at McLean Hospital, today I officially start at @UCIrvine, where I will be the founding director of a new depression

[Tulip Marawi, MSc🌷 @TulipMarawi]

#SOBP2025 is happening in Toronto this year!🇨🇦 Really excited to attend for the first time & present exciting work on the relationships between functional connectivity x cognition in collaboration with @peterzhukovsky 🙌🏻

If you’re also attending #SOBP2025, let’s connect!

[Peter Zhukovsky @peterzhukovsky]

@AVoineskos @ACNPorg Congratulations Aristotle, super well deserved!!! 🎉🎉🎉

[JAMA Psychiatry @JAMAPsych]

An increase in amygdala reactivity was associated with risk of relapse after antidepressant discontinuation and may represent a functional neuroimaging marker that could inform clinical decisions around antidepressant discontinuation. https://t.co/W0vHIuPhIO

[Peter Zhukovsky @peterzhukovsky]

@misicbata @JustineYHansen @NatureNeuro @HBHLMcGill @TheNeuro_MNI @mcgillu @NSERC_CRSNG @CIHR_IRSC @BigBrainProject @BrainCanada @MichaelJFoxOrg Very cool results!

[UofTPsychiatry @UofTPsych]

A new study by Drs. @peterzhukovsky @DanielFelsky and @AVoineskos is shedding light on the importance of treating risk factors – such as depression and cardiovascular disease – to help minimize the risk of cognitive disorders later in life.

https://t.co/I0uECGHPik #ImPACT

[Michael Fox @foxmdphd]

Where should we target TMS to treat #PTSD? New paper by @shansiddiqi @Brain_Circuits out today in @NatureNeuro identifies a target based on focal brain lesions.

[Andrew Zalesky @AndrewZalesky]

JUST OUT in Nature Mental Health:

Mapping functional connectivity in youth with depression

Largest fMRI sample of youth with MDD curated to date

Are depression-related FC changes in youth consistent with those in adults?

New work by @connie_tse1 & @cashmachine15 & team